Historique
Périodique
The epidemiology of hepatitis C among injecting drug users in Belgium
(Epidémiologie de l'hépatice C chez les usagers de drogues par injection en Belgique)
Auteur(s) :
MATHEI, C. ;
ROBAEYS, G. ;
VAN RANST M. ;
VAN DAMME, P. ;
BUNTINX F.
Année
2005
Page(s) :
50-54
Sous-type de document :
Revue de la littérature / Literature review
Langue(s) :
Français
Refs biblio. :
56
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus géographique
BELGIQUE
Thésaurus mots-clés
INJECTION
;
INFECTION
;
HEPATITE
;
EPIDEMIOLOGIE DESCRIPTIVE
;
PREVALENCE
;
GENETIQUE
;
PREVENTION
Note générale :
Acta Gastro-Enterologica Belgica, 2005, 68, (1), 50-54
Note de contenu :
graph. ; tabl.
Résumé :
ENGLISH :
In industrialised countries, injecting drug use is currently the most important risk factor for infection with hepatitis C, resulting in high prevalence rates of hepatitis C among injecting drug users. To contain the hepatitis C epidemic major efforts should be done to prevent new infection among injecting drug users. Monitoring infection rates are crucial as it may provide feedback on the effectiveness of interventions. In this article the epidemiology of hepatitis C among injecting drug users in Belgium is briefly reviewed. More specifically the prevalence of anti-HCV antibodies, the prevalence of co-infections, the proportion of chronic HCV carriers, the distribution of genotypes and preventive measures among injecting drug users in Belgium are discussed and compared to the situation elsewhere in Western Europe. (Author' s abstract)
Affiliation :
Dept of General Practice, Katholieke Universiteit Leuven, Leuven. Email : catharina.mathei@pandora.be
Belgique. Belgium.
Belgique. Belgium.
Cote :
A02418